Sunday, 5 July 2020

Costa Rica Suspends Use of Hydroxychloroquine to Treat COVID-19 Patients

The suspension is a temporary measure while the CCSS endorses a research protocol on the use of the drug hydroxychloroquine

Health Costa Rica Suspends Use of Hydroxychloroquine to Treat COVID-19 Patients

The suspension is a temporary measure while the CCSS endorses a research protocol on the use of the drug hydroxychloroquine

(QCOSTARICA) The Costa Rican Social Security Fund (Caja Costarricense de Seguro Social – CCSS) suspended the use of hydroxychloroquine in patients with COVID-19.

Through a press release, they Caja said that from today (Thursday) the temporary suspension of hydroxychloroquine.

Dr. Mario Ruiz Cubillo, medical manager of the CCSS confirmed the suspension of hydroxychloroquine and withdrawal of the administration of lopinavir-ritonavir are ordered as treatment for COVID-19 patients after the recommendation of the Central Committee of Pharmacotherapy (CCF).

- payin the bills -

The committee reviewed the evidence published until May 25, 2020, regarding the effectiveness of these 2 drugs at the international level in order to decide the relevance of maintaining treatment in the midst of the COVID-19 pandemic.

Ruiz was emphatic that it is a temporary measure while the CCSS endorses a research protocol on the use of the drug hydroxychloroquine.

He added that “every time new information on therapies for COVID-19 appears, the CCF analyzes it to assess whether the therapies that are implemented in the Institution are modified.”

According to the specialist, protocols are subject to constant change, especially in situations of health emergencies, in the Costa Rica context and in the face of this new disease and in light of the scientific evidence generated in the world.

- paying the bills -

For her part, Dr. Angélica Vargas Camacho, head of the Area of ​​Medicines and Clinical Therapeutics, of the Pharmacoepidemiology Directorate, pointed out that the Central Committee of Pharmacotherapy supports the decision.

“In the best scientific evidence, which allows making reliable decisions on the Selection of drugs with proven efficacy and safety, under this principle, the use of hydroxychloroquine for patients infected with COVID-19 was supported.

“As explained, as a precautionary measure, based on the new update of the scientific information published to date and considering the position of the World Health Organization (WHO), as an international reference entity, the Committee recommended the temporary suspension of the treatment of hydroxychloroquine and withdrawal of lopinavir ritonavir for COVID-19.

“This measure is temporary while the institution endorses a research protocol by a scientific ethical committee, in response to the WHO recommendation of “use only in the framework of duly registered, approved and ethically accepted research studies,” explained Dr. Vargas.

Ruiz added that the CCSS is respectful of the WHO recommendations, however, he emphasized that the institution has the technical capacity to define “the pharmacological management strategy as to public health measures and always seeking the greatest benefit for our patients”.

Likewise, he mentioned that to date, no medicine has an official approved indication for the treatment of COVID-19, as recognized by the international body.

- paying the bills --

Dr. Vargas reiterated that hydroxychloroquine in the institutional context has been used for many years in various pathologies, including the treatment of malaria and also of chronic diseases with an immunological component, such as rheumatoid arthritis and systemic lupus erythematosus, which is why has extensive clinical experience of use in these indications.

She also emphasized that no medication is innocuous, therefore, the prescribing physician must always make the clinical assessment of the patient prior to prescribing the medication, thinking of the greatest therapeutic benefit.

“All patients receive information about the benefit and possible adverse effects of the treatment and sign their consent under informed consent,” she said.

Likewise, the CCSS affirms that it guarantees the daily individualized follow-up of COVID-19 patients to monitor and control the clinical evolution and possible effects that they present with the use of the drug.


"Rico" is the crazy mind behind the Q media websites, a series of online magazines where everything is Q! In these times of new normal, stay at home. Stay safe. Stay healthy.

Related Articles

Alajuelita: Life on “Orange Alert”

(QCOSTARICA) That a town is on orange alert means that the...

‘Post mortem’ test confirms victim 19 of new coronavirus in Costa Rica

(QCOSTARICA) Costa Rica recorded on Saturday night death number 19 of...


24 patients with COVID-19 who have received convalescent plasma

(QCOSTARICA) Amid the bad news of the sharp increase in cases and hospitalizations this week, the good news is that 24 people with COVID-19...

Costa Rica “Hammers” Down For 10 Days

(QCOSTARICA) Apply the term used by Costa Rican President Carlos Alvarado "hammer and dance" (martillo y baile), we heard today the anticipated measures to...

Sinart employees demonstrate for layoffs

(QCOSTARICA) With the proper distancing and masks on their faces, a group of employees is holding a demonstration on the outskirts of the Sinart,...

With lower cost for business, Costa Rica will enjoy 16 long weekends

(QCOSTARICA) The bill that transfers the holidays for the following or previous Monday, with the aim of promoting local tourism, economic recovery, and job...

There are still those who don’t get it…

Rico's TICO BULL - Browsing social networks I still am amazed at how some, at times, seems many still haven't gotten the facts straight...

Daniel Salas affirms that the country can still flatten the curve

(QCOSTARICA) Although the 294 new cases of COVID-19 reported Wednesday will force the country to step back on measures to reopen, Health Minister, Daniel...

Let's Keep This Going!

To be updated with all the latest news and information about Costa Rica and Latin America.